PolyTechnos Venture-Partners

ColorChip designs and manufactures optical sub-systems and components for the Datacom and Telecom markets. These sub-systems and components are based on Application Specific Photonic Integrated Circuits (ASPICs) that leverage the company's unique and robust PLC technology.

Panoratio was established in March, 2003, in Munich, Germany. The technology grew out of work started at the Siemens AG Artificial Intelligence / Machine Learning Laboratory to address optimization issues regarding the installation and performance of gas turbine engines within Siemens Westinghouse power plants. While sensors placed throughout the power plant generated extremely complex datasets, it proved impossible to close the performance loop and analyze them efficiently. Researchers solved this problem by developing of a pure software solution that reduces the dataset's footprint without losing any of its granularity or complexity. Recognizing the universal value of the solution, Siemens AG, established Panoratio as a separate, independent entity. Since then, Panoratio has developed PANOsight, a software suite underpinned by the patented compression technology, and has over 50 customers in production. The company is proud to count AOK, AOL, Avis, buch.de, InsightHealth, KarstadtQuelle, Macy's, SavaSeniorCare, Sierra Health Services, Siemens, Sixt, Vodafone and Yahoo! among them.

Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.

Varioptic pioneers in designing and manufacturing electrically controlled optical liquid lenses for optical designers. In order to maintain its technology leadership, Varioptic heavily invests in R&D for the further development of innovative products for various applications. Founded in 2002, Varioptic is located in Lyon (France) and headed by Etienne Paillard, CEO.

Nanotron Technologies is a leader in the development of wireless products that combine high speed data transmission and location information at about 1 meter accuracy. Their wireless technology guarantees high signal robustness and low energy consumption. Nanotron's key product nanoLOC delivers both wireless communication and location in one solution. The wireless industry has many technologies for wireless communication and has some solutions for location, but only nanoLOC delivers both in one chip.

IMI Intelligent Medical Implants develops and markets intelligent retinal implant systems for degenerative retinal disorders. The company offers The Intelligent Retinal Implant System, an adaptive visual prosthesis that bridges and replaces the defective information processing function of the real retina in patients with retinal degeneration. IMI Intelligent Medical Implants was founded in 2002 and is based in Zug, Switzerland.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Varioptic pioneers in designing and manufacturing electrically controlled optical liquid lenses for optical designers. In order to maintain its technology leadership, Varioptic heavily invests in R&D for the further development of innovative products for various applications. Founded in 2002, Varioptic is located in Lyon (France) and headed by Etienne Paillard, CEO.

Panoratio was established in March, 2003, in Munich, Germany. The technology grew out of work started at the Siemens AG Artificial Intelligence / Machine Learning Laboratory to address optimization issues regarding the installation and performance of gas turbine engines within Siemens Westinghouse power plants. While sensors placed throughout the power plant generated extremely complex datasets, it proved impossible to close the performance loop and analyze them efficiently. Researchers solved this problem by developing of a pure software solution that reduces the dataset's footprint without losing any of its granularity or complexity. Recognizing the universal value of the solution, Siemens AG, established Panoratio as a separate, independent entity. Since then, Panoratio has developed PANOsight, a software suite underpinned by the patented compression technology, and has over 50 customers in production. The company is proud to count AOK, AOL, Avis, buch.de, InsightHealth, KarstadtQuelle, Macy's, SavaSeniorCare, Sierra Health Services, Siemens, Sixt, Vodafone and Yahoo! among them.

BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Venture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Varioptic pioneers in designing and manufacturing electrically controlled optical liquid lenses for optical designers. In order to maintain its technology leadership, Varioptic heavily invests in R&D for the further development of innovative products for various applications. Founded in 2002, Varioptic is located in Lyon (France) and headed by Etienne Paillard, CEO.